Medical Conditions Requiring Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy (HBOT) has two primary emergency indications where it is mandatory: carbon monoxide poisoning (especially in pregnancy) and decompression sickness/arterial gas embolism, plus several conditional indications where it serves as adjunctive therapy when standard care fails.
Mandatory/Emergency Indications
Carbon Monoxide Poisoning
HBOT is always indicated in pregnant women with CO exposure, regardless of COHb level or symptoms 1. This is the only absolute indication where HBOT is mandatory.
For non-pregnant patients with CO poisoning, HBOT should be considered when:
- Neurological symptoms (loss of consciousness, altered mental status, seizures, focal deficits) persist despite normobaric oxygen
- Cardiac symptoms (myocardial ischemia, arrhythmias) or metabolic acidosis persist despite normobaric oxygen
- Severe neurological or cardiac symptoms occurred within 24 hours of exposure
- Regardless of COHb level - the clinical condition, not the lab value, drives the decision 1
Critical timing: HBOT is most effective when initiated within 6 hours of exposure, ideally within 3 hours 20 minutes. Delays beyond 200 minutes increase delayed neurological sequelae risk 19-fold. Treatment beyond 24 hours lacks evidence support 1.
Protocol: 2.2-2.8 ATA for 60-120 minutes. A second session within 24 hours may be considered if response is inadequate; further sessions are case-by-case 1.
Decompression Sickness and Arterial Gas Embolism
HBOT is the primary treatment for diving-related pressure injuries 2, 3. These are pressure-related indications where HBOT addresses the underlying pathophysiology directly.
Conditional/Adjunctive Indications
Diabetic Foot Ulcers
Consider HBOT only for neuro-ischemic or ischemic diabetic foot ulcers that have failed standard care (including appropriate off-loading) for at least 2 weeks, and only where hyperbaric facilities already exist 4.
The evidence is low certainty but shows moderate benefit in wound healing and ulcer area reduction, though no amputation reduction was demonstrated. This is resource-intensive (weeks of daily treatment) and limited to patients without significant frailty or comorbidities who can tolerate the therapy 4.
Other Wound-Related Conditions
HBOT may be considered as adjunctive therapy when standard care fails for 5, 6, 3:
- Compromised skin grafts and flaps
- Crush injuries with tissue ischemia
- Necrotizing soft tissue infections
- Chronic non-healing ulcers with arterial insufficiency
- Thermal burns (as adjunct)
- Radiation-induced tissue injury
Central Retinal Artery Occlusion
HBOT may benefit acute central retinal artery occlusion when administered emergently 3.
Important Caveats
Common pitfalls to avoid:
- Do not use COHb levels alone to determine HBOT need in CO poisoning - clinical symptoms trump lab values 1
- Do not delay normobaric oxygen while arranging HBOT - high-flow oxygen (8-12 L/min via non-rebreather) is lifesaving and must start immediately 1
- Balance transport risks against HBOT benefits - unstable patients may be harmed by transfer 1
- Do not use HBOT for acute ischemic stroke - evidence shows no benefit or potential harm 2
Contraindications requiring careful consideration:
- Untreated pneumothorax (absolute contraindication)
- Uncontrolled hypertension
- Severe COPD with CO2 retention
- Claustrophobia (relative)
- Pregnancy is NOT a contraindication for CO poisoning 7
Resource considerations: HBOT requires specialized facilities, trained personnel, and significant time commitment (typically 20-40 sessions for wound indications). Recommendations assume existing infrastructure - building new facilities solely for these indications is not cost-effective 4.
The evidence base varies considerably: CO poisoning recommendations rest on observational cohort data rather than RCTs, while diabetic foot ulcer evidence includes some low-risk-of-bias RCTs showing conflicting results 1, 4. When in doubt for CO poisoning with persistent symptoms despite oxygen, favor HBOT given the devastating consequences of delayed neurological sequelae 1.